Research Facility

Salt Lake City, Utah 84132

2 studies enrolling now · 11 studies all time

What they study most

Advanced Breast Cancer, Arrhythmias, Carcinoid, Carcinoid Tumor, Chronic Constipation, Chronic Pain, ER+ Breast Cancer, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, HER2-negative Breast Cancer, Hematopoietic Stem Cell Transplant

Studies at this site

• Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT). — Completed
• Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC — Running, not enrolling
• Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. — Running, not enrolling
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee — Completed
• A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome — Stopped early
• Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation — Stopped early